Free Trial

Rockefeller Capital Management L.P. Sells 13,970 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background

Rockefeller Capital Management L.P. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 156,717 shares of the medical equipment provider's stock after selling 13,970 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in Intuitive Surgical were worth $81,768,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Petros Family Wealth LLC acquired a new position in Intuitive Surgical in the fourth quarter worth about $1,081,000. Sterling Capital Management LLC increased its position in Intuitive Surgical by 4.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,577 shares of the medical equipment provider's stock worth $9,696,000 after buying an additional 790 shares during the period. Concorde Asset Management LLC grew its position in shares of Intuitive Surgical by 21.2% during the fourth quarter. Concorde Asset Management LLC now owns 554 shares of the medical equipment provider's stock worth $289,000 after acquiring an additional 97 shares during the last quarter. Coign Capital Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth about $651,000. Finally, Heritage Trust Co bought a new position in Intuitive Surgical in the 4th quarter worth about $917,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on ISRG shares. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Truist Financial reduced their price target on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a report on Monday, March 17th. Robert W. Baird dropped their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 18th. Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, UBS Group raised their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $611.81.

View Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Trading Up 1.1 %

NASDAQ:ISRG traded up $5.32 during midday trading on Thursday, hitting $486.66. 938,642 shares of the stock were exchanged, compared to its average volume of 1,599,547. The company has a market capitalization of $173.34 billion, a price-to-earnings ratio of 76.06, a P/E/G ratio of 5.85 and a beta of 1.55. The business has a 50-day moving average price of $526.67 and a two-hundred day moving average price of $532.10. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines